Search
  • mirailabbio

Patents on eNAMPT-EVs

Updated: Jun 23

Mirailab Bioscience, Inc. and The Institute for Research on Productive Aging (IRPA; Representative Director: Prof. Shinichiro Imai) have jointly applied for a patent on eNAMPT-EVs.


Details of the patent application.

A method for purification of human eNAMPT-EVs, a method for obtaining an anti-aging effect by administering an anti-aging composition containing purified eNAMPT-EVs to a subject, and a method for determining the degree of aging.


For the implementation of the method of obtaining an anti-aging effect and the method of determining the degree of aging using eNAMPT-EVs, as of April 1, 2022, Mirailab Bioscience Corporation's medical support business, Miraikai Medical Corporation/Tokyo Ginza Wellness & Aging Clinic, has welcomed IRPA researchers to its in-house laboratory and has begun joint research with IRPA.


*Miraikai Medical Corporation/Tokyo Ginza Wellness & Aging Clinic, where Professor Shinichiro Imai (Washington University School of Medicine, St. Louis, MO, M. and T. Tanaka Family Distinguished Professor in Aging Research) serves on the board of directors.


Productive Aging Research Organization

https://www.irpa.ne.jp/en/

Miraikai Medical Corporation

https://www.mirai-kai.or.jp/

Tokyo Ginza Wellness & Aging Clinic

https://tgwaclinic.com/

35 views0 comments